ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 294 filers reported holding ARGENX SE in Q2 2023. The put-call ratio across all filers is 1.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $376,715 | +0.1% | 876 | -8.4% | 0.00% | 0.0% |
| Q1 2024 | $376,396 | -3.8% | 956 | -7.0% | 0.00% | 0.0% |
| Q4 2023 | $391,082 | -22.4% | 1,028 | +0.3% | 0.00% | -50.0% |
| Q3 2023 | $503,921 | +40.7% | 1,025 | +11.5% | 0.00% | +100.0% |
| Q2 2023 | $358,162 | +10.4% | 919 | +5.5% | 0.00% | 0.0% |
| Q1 2023 | $324,517 | -1.3% | 871 | +0.3% | 0.00% | -50.0% |
| Q4 2022 | $328,824 | +123.7% | 868 | +106.7% | 0.00% | 0.0% |
| Q4 2021 | $147,000 | +8.1% | 420 | -6.7% | 0.00% | 0.0% |
| Q3 2021 | $136,000 | -9.9% | 450 | -10.5% | 0.00% | 0.0% |
| Q2 2021 | $151,000 | +8.6% | 503 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $139,000 | -10.9% | 503 | -5.1% | 0.00% | -33.3% |
| Q4 2020 | $156,000 | +21.9% | 530 | -52.9% | 0.00% | 0.0% |
| Q3 2019 | $128,000 | – | 1,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
| Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
| Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
| MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
| AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
| EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
| INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
| Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
| DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
| Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |